Kyverna Therapeutics, Inc. (KYTX)

CIK 1994702 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kyverna Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001193125-26-350332
Aug 11, 202610-Q0001193125-26-344607
Aug 11, 20268-K0001193125-26-344572
Jul 29, 2026SCHEDULE 13G0002012383-26-002893
Jul 27, 20268-K0001193125-26-316916
Jul 9, 20268-K0001193125-26-298979
Jun 2, 20268-K0001193125-26-253604
May 29, 202640001193125-26-248434
May 29, 202640001193125-26-248425
May 29, 202640001193125-26-248429
May 29, 202640001193125-26-248435
May 29, 202640001193125-26-248427
May 20, 202630001193125-26-232683
May 20, 202640001193125-26-232681
May 18, 20268-K0001193125-26-227920
May 12, 20268-K0001193125-26-219377
May 12, 202610-Q0001193125-26-219397
May 6, 202630001193125-26-209119
May 6, 202640001193125-26-209120
May 4, 20268-K0001193125-26-202610
Apr 22, 20268-K0001193125-26-167512
Apr 22, 20268-K0001193125-26-168287
Apr 20, 20268-K0001193125-26-162755
Apr 17, 20261440001950047-26-003607
Apr 14, 20261440001950047-26-003454